Acceptance and Commitment Therapy (ACT) for Anxious Cancer Survivors
Status: | Recruiting |
---|---|
Conditions: | Cancer, Cancer |
Therapuetic Areas: | Oncology |
Healthy: | No |
Age Range: | 21 - 95 |
Updated: | 8/2/2018 |
Start Date: | September 2015 |
End Date: | June 2019 |
Contact: | Joanna Arch, Ph.D. |
Email: | Joanna.Arch@Colorado.edu |
Phone: | 303-492-4634 |
A Novel Acceptance-Based Intervention for Anxious Cancer Survivors
This randomized clinical trial compares group acceptance and commitment therapy (ACT) to
usual care for cancer survivors experiencing anxiety following the end of cancer treatment.
usual care for cancer survivors experiencing anxiety following the end of cancer treatment.
Inclusion Criteria:
1. Adults in the Greater Boulder/ Denver, Colorado area who had cancer and completed
primary cancer treatment (surgery, chemotherapy, and/or radiation) within the previous
18 months
2. For solid tumor cancers: Show no current evidence of disease for solid-tumor cancers
(of any cancer type or initial stage). For lymphoproliferative disorders such as
chronic lymphocytic leukemia and indolent non-Hodgkin's lymphoma: In remission or
asymptomatic after initial treatment and are followed with active surveillance.
3. Screen positive for anxiety symptoms on the study screener
4. Able to speak, read, and write English fluently
5. Willing and able to participate in an ACT group once a week for 7 weeks
6. Willing and able to complete online questionnaires and phone interviews at designated
assessment points
Exclusion Criteria:
1. Current moderate to high suicide risk
2. History of chronic untreated trauma (unrelated to their cancer)
3. Psychiatric hospitalization or suicide attempt in the past 5 years
We found this trial at
1
site
University of Colorado, Boulder As the flagship university of the state of Colorado, CU-Boulder is...
Click here to add this to my saved trials